Related Articles
Prevalence of <em>BRCA1</em> and <em>BRCA2</em> mutations in Japanese patients with triple‑negative breast cancer: A single institute retrospective study
Multicenter cross‑sectional screening of the BRCA gene for Chinese high hereditary risk breast cancer populations
Elevated expression of Ki-67 identifies aggressive prostate cancers but does not distinguish BRCA1 or BRCA2 mutation carriers
The PARP inhibitor AZD2281 (Olaparib) induces autophagy/mitophagy in BRCA1 and BRCA2 mutant breast cancer cells
Characterization of mutations in BRCA1/2 and the relationship with clinic‑pathological features of breast cancer in a hereditarily high‑risk sample of chinese population